Search research articles
Contact Us
Filters
Showing results (371-380 of 401) with videos related to
Page
of 41
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Nature
|
July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Cancer Discovery
|
December 17, 2017
Accelerating Discovery of Functional Mutant Alleles in Cancer
Matthew T Chang, Tripti Shrestha Bhattarai, Alison M Schram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Maeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
Nature
|
December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
The New England Journal of Medicine
|
February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors
Eric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Journal of the National Cancer Institute
|
March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
Maeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Cancer Discovery
|
October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
James J Harding, Maeve A Lowery, Alan H Shih, et al.
Cancer Discovery
|
June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
Alexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
Nature Medicine
|
November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 401) with videos related to
Sort By:
Page
of 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Nature
|
July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Cancer Discovery
|
December 17, 2017
Accelerating Discovery of Functional Mutant Alleles in Cancer
Matthew T Chang, Tripti Shrestha Bhattarai, Alison M Schram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Maeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
Nature
|
December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
The New England Journal of Medicine
|
February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors
Eric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Journal of the National Cancer Institute
|
March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
Maeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Cancer Discovery
|
October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
James J Harding, Maeve A Lowery, Alan H Shih, et al.
Cancer Discovery
|
June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
Alexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
Nature Medicine
|
November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Page
of 41